MedPath
NMPA Approval

Pasireotide Diaspartate Injection

国药准字H20254400

May 27, 2025

Drug Information

门冬氨酸帕瑞肽注射液

注射剂

1ml:0.6mg(按C₅₈H₆₆N₁₀O₉计)

化学药品

May 27, 2025

Company Information

Applicant Company

硚口区硚口路160号1幢23层1-6号

Manufacturing Company

湖北省武汉市东西湖区金银湖生态园环湖中路11号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬氨酸帕瑞肽注射液 - NMPA 批准文号 | MedPath